Woolworths-backed telehealth start-up Eucalyptus has doubled its annual revenue to almost $250 million as sales of GLP-1 weight loss drugs…
Read More

Woolworths-backed telehealth start-up Eucalyptus has doubled its annual revenue to almost $250 million as sales of GLP-1 weight loss drugs…
Read More
After abandoning the development of an oral weight-loss drug, Pfizer is obtainting back in the game. The US pharma giant…
Read More